214 related articles for article (PubMed ID: 29197093)
1. The association between irisin and muscle metabolism in different thyroid disorders.
Zybek-Kocik A; Sawicka-Gutaj N; Szczepanek-Parulska E; Andrusiewicz M; Waligórska-Stachura J; Białas P; Krauze T; Guzik P; Skrobisz J; Ruchała M
Clin Endocrinol (Oxf); 2018 Mar; 88(3):460-467. PubMed ID: 29197093
[TBL] [Abstract][Full Text] [Related]
2. Serum irisin levels and thyroid function--newly discovered association.
Ruchala M; Zybek A; Szczepanek-Parulska E
Peptides; 2014 Oct; 60():51-5. PubMed ID: 25102448
[TBL] [Abstract][Full Text] [Related]
3. Titin and dystrophin serum concentration changes in patients affected by thyroid disorders.
Zybek-Kocik A; Sawicka-Gutaj N; Domin R; Szczepanek-Parulska E; Krauze T; Guzik P; Ruchała M
Endokrynol Pol; 2021; 72(1):1-7. PubMed ID: 33295636
[TBL] [Abstract][Full Text] [Related]
4. Circulating irisin concentrations in rat models of thyroid dysfunction -- effect of exercise.
Samy DM; Ismail CA; Nassra RA
Metabolism; 2015 Jul; 64(7):804-13. PubMed ID: 25720940
[TBL] [Abstract][Full Text] [Related]
5. Time-dependent irisin concentration changes in patients affected by overt hypothyroidism.
Zybek-Kocik A; Sawicka-Gutaj N; Wrotkowska E; Sowiński J; Ruchała M
Endokrynol Pol; 2016; 67(5):476-480. PubMed ID: 26884299
[TBL] [Abstract][Full Text] [Related]
6. Irisin and FNDC5: effects of 12-week strength training, and relations to muscle phenotype and body mass composition in untrained women.
Ellefsen S; Vikmoen O; Slettaløkken G; Whist JE; Nygaard H; Hollan I; Rauk I; Vegge G; Strand TA; Raastad T; Rønnestad BR
Eur J Appl Physiol; 2014 Sep; 114(9):1875-88. PubMed ID: 24906447
[TBL] [Abstract][Full Text] [Related]
7. Changes in Thyroid Hormone Levels Within the Normal and/or Subclinical Hyper- or Hypothyroid Range Do Not Affect Circulating Irisin Levels in Humans.
Panagiotou G; Pazaitou-Panayiotou K; Paschou SA; Komninou D; Kalogeris N; Vryonidou A; Mantzoros CS
Thyroid; 2016 Aug; 26(8):1039-45. PubMed ID: 27267080
[TBL] [Abstract][Full Text] [Related]
8. Both hypothyroidism and hyperthyroidism increase plasma irisin levels in rats.
Atici E; Mogulkoc R; Baltaci AK; Menevse E
Horm Mol Biol Clin Investig; 2017 Nov; 33(3):. PubMed ID: 29182513
[TBL] [Abstract][Full Text] [Related]
9. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise.
Huh JY; Panagiotou G; Mougios V; Brinkoetter M; Vamvini MT; Schneider BE; Mantzoros CS
Metabolism; 2012 Dec; 61(12):1725-38. PubMed ID: 23018146
[TBL] [Abstract][Full Text] [Related]
10. The role of sex, adiposity, and gonadectomy in the regulation of irisin secretion.
Zügel M; Qiu S; Laszlo R; Bosnyák E; Weigt C; Müller D; Diel P; Steinacker JM; Schumann U
Endocrine; 2016 Oct; 54(1):101-110. PubMed ID: 27055554
[TBL] [Abstract][Full Text] [Related]
11. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance.
Moreno-Navarrete JM; Ortega F; Serrano M; Guerra E; Pardo G; Tinahones F; Ricart W; Fernández-Real JM
J Clin Endocrinol Metab; 2013 Apr; 98(4):E769-78. PubMed ID: 23436919
[TBL] [Abstract][Full Text] [Related]
12. Hyperirisinemia is independently associated with subclinical hypothyroidism: correlations with cardiometabolic biomarkers and risk factors.
Stratigou T; Dalamaga M; Antonakos G; Marinou I; Vogiatzakis E; Christodoulatos GS; Karampela I; Papavassiliou AG
Endocrine; 2018 Jul; 61(1):83-93. PubMed ID: 29455364
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of irisin is elevated in hypothyroidism, a case-control study.
Ateş İ; Altay M; Topçuoğlu C; Yılmaz FM
Arch Endocrinol Metab; 2016 Apr; 60(2):95-100. PubMed ID: 26201007
[TBL] [Abstract][Full Text] [Related]
14. Thyroid hormones modulate irisin concentrations in patients with recently onset hypothyroidism following total thyroidectomy.
Bocale R; Barini A; D'Amore A; Boscherin M; Necozione S; Barini A; Desideri G; Lombardi CP
J Endocrinol Invest; 2021 Jul; 44(7):1407-1412. PubMed ID: 33058006
[TBL] [Abstract][Full Text] [Related]
15. Circulating Irisin Level and Thyroid Dysfunction: A Systematic Review and Meta-Analysis.
Shan D; Zou L; Liu X; Cai Y; Dong R; Hu Y
Biomed Res Int; 2020; 2020():2182735. PubMed ID: 33195690
[TBL] [Abstract][Full Text] [Related]
16. Irisin and Myostatin Levels in Patients with Graves' Disease.
Yalcin MM; Akturk M; Tohma Y; Cerit ET; Altinova AE; Arslan E; Yetkin I; Toruner FB
Arch Med Res; 2016 Aug; 47(6):471-475. PubMed ID: 27986127
[TBL] [Abstract][Full Text] [Related]
17. Role of irisin in Chinese patients with hypothyroidism: an interventional study.
Yang N; Zhang H; Gao X; Miao L; Yao Z; Xu Y; Wang G
J Int Med Res; 2019 Apr; 47(4):1592-1601. PubMed ID: 30722716
[TBL] [Abstract][Full Text] [Related]
18. Associations of Circulating Irisin with FNDC5 Expression in Fat and Muscle in Type 1 and Type 2 Diabetic Mice.
Jiang S; Piao L; Ma EB; Ha H; Huh JY
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33672565
[TBL] [Abstract][Full Text] [Related]
19. The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans.
Norheim F; Langleite TM; Hjorth M; Holen T; Kielland A; Stadheim HK; Gulseth HL; Birkeland KI; Jensen J; Drevon CA
FEBS J; 2014 Feb; 281(3):739-49. PubMed ID: 24237962
[TBL] [Abstract][Full Text] [Related]
20. Treatment of severe thyroid function disorders and changes in body composition.
Stangierski A; Ruchała M; Krauze T; Moczko J; Guzik P
Endokrynol Pol; 2016; 67(4):359-66. PubMed ID: 26884294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
